Detecting potential safety issues in clinical trials by Bayesian screening
From MaRDI portal
Recommendations
- Accounting for multiplicity in the evaluation of ``signals obtained by data mining from spontaneous report adverse event databases
- Data mining of the Australian adverse drug reactions database: a comparison of Bayesian and other statistical indicators
- Efficient methods for signal detection from correlated adverse events in clinical trials
- scientific article; zbMATH DE number 4155731
- Bayesian statistics and the efficiency and ethics of clinical trials
Cited in
(7)- Multivariate Bayesian logistic regression for analysis of clinical study safety issues
- Bayesian approach for clinical trial safety data using an Ising prior
- Data mining of the Australian adverse drug reactions database: a comparison of Bayesian and other statistical indicators
- Accounting for multiplicity in the evaluation of ``signals obtained by data mining from spontaneous report adverse event databases
- Efficient methods for signal detection from correlated adverse events in clinical trials
- Use of the false discovery rate for evaluating clinical safety data
- Unified screening for potential elevated adverse event risk and other associations
This page was built for publication: Detecting potential safety issues in clinical trials by Bayesian screening
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5123117)
